SNX10 and precursor B-cell acute lymphoblastic leukemia: Collectively, these findings highlighted the pivotal role of SNX10 in promoting B-ALL cell proliferation via the PI3K pathway, highlighting its potential as a therapeutic target for B-ALL and providing a foundation for future investigations.